SBC Medical Group Holdings (SBC) Stock Overview
Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
SBC Community Fair Values
Create NarrativeSee what 73 others think this stock is worth. Follow their fair value or set your own to get alerts.
SBC Medical Group Holdings Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.48 |
| 52 Week High | US$12.50 |
| 52 Week Low | US$2.62 |
| Beta | 1.27 |
| 1 Month Change | 0.45% |
| 3 Month Change | 0.90% |
| 1 Year Change | -59.42% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -55.02% |
Recent News & Updates
Why We Like The Returns At SBC Medical Group Holdings (NASDAQ:SBC)
Jul 10
SBC Medical Group Holdings' (NASDAQ:SBC) Weak Earnings May Only Reveal A Part Of The Whole Picture
May 23Recent updates
Why We Like The Returns At SBC Medical Group Holdings (NASDAQ:SBC)
Jul 10SBC Medical Group Holdings' (NASDAQ:SBC) Weak Earnings May Only Reveal A Part Of The Whole Picture
May 23SBC Medical: Scalable Profits Undermined By Governance Overhang, Still Worth A Look
May 08SBC Medical Group Holdings (NASDAQ:SBC) Seems To Use Debt Rather Sparingly
Mar 12A New Addition to my 2025 Global Portfolio?
This Japanese-based company, SBC Medical Group Holdings Inc. (NASDAQ: SBC) is now making waves in the aesthetic healthcare market, offering a promising opportunity for investors in 2025. After itHidden Gem (NASDAQ: SBC), Empowering the Growth of Aesthetic Medicine
Hidden Gem (NASDAQ: SBC), Empowering the Growth of Aesthetic MedicineSBC Medical Group Holdings (NASDAQ: SBC) is making waves in the aesthetic medicine industry with its dynamic growth strategy and roSBC Medical Group Holdings' (NASDAQ:SBC) Promising Earnings May Rest On Soft Foundations
Nov 20Shareholder Returns
| SBC | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 8.0% | 4.0% | 1.7% |
| 1Y | -59.4% | -24.3% | 18.7% |
Return vs Industry: SBC underperformed the US Healthcare industry which returned -24.4% over the past year.
Return vs Market: SBC underperformed the US Market which returned 18.5% over the past year.
Price Volatility
| SBC volatility | |
|---|---|
| SBC Average Weekly Movement | 10.2% |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SBC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: SBC's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 863 | Yoshiyuki Aikawa | sbc-holdings.com |
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; facility rental services; construction and design services for franchisee clinics; and medical consumables procurement services. It also provides program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers.
SBC Medical Group Holdings Incorporated Fundamentals Summary
| SBC fundamental statistics | |
|---|---|
| Market cap | US$461.88m |
| Earnings (TTM) | US$33.33m |
| Revenue (TTM) | US$188.19m |
Is SBC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SBC income statement (TTM) | |
|---|---|
| Revenue | US$188.19m |
| Cost of Revenue | US$43.34m |
| Gross Profit | US$144.86m |
| Other Expenses | US$111.52m |
| Earnings | US$33.33m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.32 |
| Gross Margin | 76.97% |
| Net Profit Margin | 17.71% |
| Debt/Equity Ratio | 4.2% |
How did SBC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/14 22:29 |
| End of Day Share Price | 2025/09/12 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SBC Medical Group Holdings Incorporated is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aashi Shah | Sidoti & Company, LLC |
| Marla Marin | Zacks Small-Cap Research |